Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under immunosuppressive therapy
Vanessa R. Guissa, MD
Rosa M.R. Pereira, MD, PhDAdriana M.E. Sallum, MD, PhDNadia E. Aikawa, MD, MScLucia M.A. Campos, MD, PhDClovis A. Silva, MD, PhD*Eloisa Bonfá, MD, PhD*
*These authors made an equal contribution to this work.
Please address correspondence to: Clovis A. Silva, MD, PhD,Rua Araioses 152/81,Vila Madalena,
05442-010 São Paulo, Brazil.E-mail: clovis.silva@icr.usp.br
Received on December 27, 2011; accepted in revised form on March 14, 2012.© Copyright EXPERIMENTALCLINICAL RHEUMATOLOGY AND
2012.
Funding: This study was supported bygrants from Fundação de Amparo àPesquisa do Estado de São Paulo
(F2010/10749-0 to EB), Conselho NacionalAPESP no. 2009/51897-5 to EB and no. de Desenvolvimento Cientí co e
Tecnológico (CNPQ no. 300559/2009-7 to RMRPno. 301411/2009-3 to EB), Federico , no. 2011/12471-2 to CAS and Foundation (to RMRPButantan Foundation, and by Núcleo de , CAS and EB), Apoio a Pesquisa “Saúde da Criança e do Adolescente” da USP (NAP-CriAd).Competing interests: none declared.
Introduction
Improvements management in the diagnosis and ositis hanced (JDM) of juvenile dermatomy-(1-4). The treatment used in these pa-survival have over signi cantly the last decades en-tients immunosuppression with a consequent and disease itself may induce increase 7). an essential prevention tool in pediatric Therefore, in infection vaccination susceptibility emerges (5-as rheumatologic disease (5, 8).
Recently, the European League Against Rheumatism reinforced the relevance of vaccination (EULAR) task force has in matologic patients, due to high risk of immunosuppressed pediatric rheu-severe in uenza infection was recommended for all immunosup-A H1N1/2009 (8). Accordingly, vaccination the pressed patient (9), due to the high in-cidence of hospitalisation and death in this particular group of patients report-ed during the 2009 pandemic (10).
There regarding are scarce data in the JDM stricted to overall immunogenicity and patients H1N1 and in uenza all of them vaccine literature are re-in safety the immune response of in uenza vac-(11-13). Ogimi et al. evaluated cine in small cohort of juvenile autoim-mune only 6 JDM patients, and reported im-rheumatic diseases, including mune response comparable to controls (11). Only 3 JDM patients were evalu-ated in the study of Kanakoudi-Tsaka-lidou conclusion et al., thus precluding a de nitive We about genicity and safety of the non-adjuvan-have recently their assessed ndings immuno-(12). ted in uenza A H1N1/2009 vaccine in 237 diseases, juvenile tients, term and including autoimmune showed only an 18 rheumatic JDM pa-sponse safety with reduced overall immune short-re-use (13), without a speci c analysis of associated with glucocorticoid this subgroup of patients.
Moreover, graphic, in disease the possible and therapy role of factors demo-potential vaccine antibody response and the disease impact of vaccine in JDM mined. Gender and age are relevant for parameters need to be deter-immunogenicity, has number higher since female gender of antibodies viral vaccine titers (14) to and a large pa-584
tients induce younger uenza lesser humoral than 9 response years old may was also identi ed to contribute to vac-A H1N1(15, 16). Treatment to in-cine response in lupus patients (17) and there vaccine were reports suggesting that the lupus erythematosus patients (18). may induce are in systemic Therefore, the objectives of this study were tion between seroconversion rate with to assess the possible associa-demographic JDM data, muscle ment possible deleterious effect of the non-in scores, JDM lymphopenia patients, as well and enzymes, as treat-the adjuvanted in uenza A H1N1/2009 in the disease itself.
Methods
Thirty including 18 JDM patients of our previ-consecutive JDM outpatients, ous study (13)Pediatric , routinely followed at the Rheumatology Division of Clinics Hos-Rheumatology Unit and the pital, São Paulo, Brazil, were included in international this study. All patients ful lled the JDM healthy (19). A classi cation total of 81 age-matched criteria for included subjects ticipants in the were concomitantly and ous exclusion were ≥9 control and ≤21 group. All years par-old, H1N1/2009, proven infection criteria included previ-vaccine components or to egg, previous anaphylactic by in uenza response to A vaccination with any live vaccine four weeks cine two weeks before the study, 2010 before or any inactivated vac-seasonal infection resulting in fever over 38°C at in uenza vaccination, acute the time of vaccination, Guillain-Barré syndrome or demyelinating syndromes, blood and hospitalisation (13).
transfusion within six months, Study design
This was a prospective, open study con-ducted between March 2010 and April 2010. All JDM patients were invited by letter to participate in the Public Health in uenza A paign H1N1/2009 vaccine cam-the at the Immunisation Centre of who came to this centre seeking vacci-same hospital. Healthy volunteers nation in response to the Public Health National control group. Campaign This were protocol included was ap-
as
Influenza (the flu)_英语学习_外语学习_教育专区。流感预防Influenza (the flu) By Salwa Hassan Teama Ain Shams University Difference Between Cold or FLU ...
流感病毒与流感疫苗 - Influenza and Influenza Vaccines_生物学_自然科学_专业资料。流感病毒与流感疫苗 - Influenza and Influenza Vaccines...
Influenza (Flu) What Everyone Should Know About Flu and the Flu Vaccine What is the flu? The flu is a contagious respiratory illness caused by ...
Influenza Miley ClassB Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the ...
Influenza (flu): ? is a highly infectious viral disease caused by various types of influenza viral strains ? Seasonal Influenza In Hong Kong, the ...
42页 免费 Influenza 32页 10财富值搜你所想,读你所爱 拒绝盗版,营造绿色文库 如要投诉违规内容,请到百度文库投诉中心;如要提出功能问题或意见建议,请点击...
www.themegallery.com Spring - prone diseases Epidemic cerebrospinal meningitis、 、 influenza , mumps and other respiratory diseases流脑、流感、流腮等呼吸道...
Summer 2008 Workshop in Biology and Multimedia for High School Teachers INFLUENZA VIRUS: A Model for Learning About Disease Laurie St.Pierre Sandwich High...
流行性感冒病毒 influenza virus 流行性感冒病毒(influenza virus)简称流感 病毒。按病毒核蛋白(nucleocapside protein,NP) 和基质蛋白(matrix protein, M)分成甲(A)...
流行性感冒 influenza 定义:流行性感冒简称流感,是 由流行性感冒病毒引起的急性呼 吸道传染病。 特征:病毒极易变异; 传染性强; 全身症状重; 呼吸道症状轻。 ...
热门文档